等待开盘 01-15 09:30:00 美东时间
-0.260
-1.11%
Jefferson Capital (JCAP) said on Monday that certain existing stockholders plan to sell 10 million shares of the company’s common stock in an underwritten secondary public offering. The underwriters w...
01-06 05:22
Jefferson Capital, Inc. announced a secondary offering of 10 million shares, with underwriters having an option to purchase up to 1.5 million additional shares. The company plans to repurchase 3 million shares, which will be retired. The offering is supported by multiple underwriters, and a preliminary prospectus is available. The press release includes customary forward-looking disclaimers and risk factors.
01-05 21:17
Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rose sharply in pre-market a...
2025-12-31 19:14
Keefe, Bruyette & Woods analyst Bose George reiterates Jefferson Capital (NASDAQ:JCAP) with a Outperform and maintains $28 price target.
2025-12-25 02:04
Jefferson Capital, Inc. (NASDAQ: JCAP) completed the acquisition of credit card assets from Bluestem Brands affiliates, with a net purchase price of $196.7 million and estimated collections of $311.4 million. Founded in 2002, Jefferson Capital is a global purchaser and manager of charged-off and active consumer accounts, operating across the U.S., Canada, the U.K., and Latin America. The company serves Fortune 500 creditors, banks, fintech platfo...
2025-12-04 21:10
U.S. stock futures were lower this morning, with the Dow futures falling around...
2025-11-25 21:01
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
Citizens analyst David M. Scharf maintains Jefferson Capital (NASDAQ:JCAP) with a Market Outperform and raises the price target from $23 to $26.
2025-11-14 23:22
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11